skip to main content
Você quis dizer: ward david?
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic factors for chemotherapy induced nausea and vomiting
Material Type:
Artigo
Adicionar ao Meu Espaço

Prognostic factors for chemotherapy induced nausea and vomiting

Warr, David

European journal of pharmacology, 2014-01, Vol.722, p.192-196 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

2
Aprepitant and Fosaprepitant: A 10‐Year Review of Efficacy and Safety
Material Type:
Artigo
Adicionar ao Meu Espaço

Aprepitant and Fosaprepitant: A 10‐Year Review of Efficacy and Safety

Aapro, Matti ; Carides, Alexandra ; Rapoport, Bernardo L. ; Schmoll, Hans‐Joachim ; Zhang, Li ; Warr, David

The oncologist (Dayton, Ohio), 2015-04, Vol.20 (4), p.450-458 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

3
Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials
Material Type:
Artigo
Adicionar ao Meu Espaço

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials

Popovic, Marko ; Warr, David G. ; DeAngelis, Carlo ; Tsao, May ; Chan, Kelvin K. W. ; Poon, Michael ; Yip, Cheryl ; Pulenzas, Natalie ; Lam, Henry ; Zhang, Liying ; Chow, Edward

Supportive care in cancer, 2014-06, Vol.22 (6), p.1685-1697 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

4
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy
Material Type:
Artigo
Adicionar ao Meu Espaço

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy

Warr, David G. ; Street, James C. ; Carides, Alexandra D.

Supportive care in cancer, 2011-06, Vol.19 (6), p.807-813 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

5
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

Pezo, Rossanna C. ; Chen, Tom W. ; Berman, Hal K. ; Mulligan, Anna M. ; Razak, Albiruni A. ; Siu, Lillian L. ; Cescon, David W. ; Amir, Eitan ; Elser, Christine ; Warr, David G. ; Sridhar, Srikala S. ; Yu, Celeste ; Wang, Lisa ; Stockley, Tracy L. ; Kamel-Reid, Suzanne ; Bedard, Philippe L.

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.159-168 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

6
Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings—a meta-analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings—a meta-analysis

Jordan, Karin ; Warr, David G. ; Hinke, Axel ; Sun, Linda ; Hesketh, Paul J.

Supportive care in cancer, 2016-05, Vol.24 (5), p.1941-1954 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

7
Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis

Chow, Ronald ; Warr, David G. ; Navari, Rudolph M. ; Tsao, May ; Popovic, Marko ; Chiu, Leonard ; Milakovic, Milica ; Lam, Henry ; DeAngelis, Carlo

Supportive care in cancer, 2018-08, Vol.26 (8), p.2519-2549 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

8
Should palonosetron be a preferred 5-HT 3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Should palonosetron be a preferred 5-HT 3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis

Chow, Ronald ; Warr, David G ; Navari, Rudolph M ; Tsao, May ; Popovic, Marko ; Chiu, Leonard ; Milakovic, Milica ; Lam, Henry ; DeAngelis, Carlo

Supportive care in cancer, 2018-08, Vol.26 (8), p.2519 [Periódico revisado por pares]

Germany

Texto completo disponível

9
Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
Material Type:
Artigo
Adicionar ao Meu Espaço

Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors

BORDELEAU, Louise ; PRITCHARD, Kathleen I ; LOPRINZI, Charles L ; ENNIS, Marguerite ; JUGOVIC, Olivera ; WARR, David ; HAQ, Rashida ; GOODWIN, Pamela J

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5147-5152 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

10
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents
Material Type:
Artigo
Adicionar ao Meu Espaço

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Jordan, Karin ; Chan, Alexandre ; Gralla, Richard J. ; Jahn, Franziska ; Rapoport, Bernardo ; Warr, David ; Hesketh, Paul J.

Supportive care in cancer, 2017-01, Vol.25 (1), p.271-275 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (196)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (212)
  2. Book Chapters  (15)
  3. Conjunto de Dados  (8)
  4. Imagens  (3)
  5. Anais de Congresso  (2)
  6. Recursos Textuais  (1)
  7. Livros  (1)
  8. Reports  (1)
  9. magazinearticle  (1)
  10. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1995  (20)
  2. 1995Até2001  (33)
  3. 2002Até2008  (47)
  4. 2009Até2016  (62)
  5. Após 2016  (70)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (243)
  2. Japonês  (30)
  3. Português  (2)
  4. Norueguês  (2)
  5. Alemão  (1)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.